The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus

The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus

OBJECTIVE: To identify the prevalence and factors associated with cervical human papillomavirus infection in women with systemic lupus erythematosus METHODS: This cross-sectional study collected traditional and systemic lupus erythematosus-related disease risk factors, including conventional and b...

Full description

Bibliographic Details
Main Authors: Claudia Mendoza-Pinto, Mario Garcia-Carrasco, Veronica Vallejo-Ruiz, Alejandro Taboada-Cole, Margarita Munoz-Guarneros, Juan Carlos Solis-Poblano, Elias Pezzat-Said, Adriana Aguilar-Lemarroy, Luis Felipe Jave-Suarez, Luis Vazquez de Lara, Gloria Ramos-Alvarez, Julio Reyes-Leyva, Aurelio Lopez-Colombo
Format: Article
Language:English
Published: Elsevier España 2013-12-01
Series:Clinics
Subjects:
Cervical Human Papillomavirus Infection
Systemic Lupus Erythematosus
Risk Factors
Rituximab
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322013001201475&lng=en&tlng=en

Similar Items

Similar Items